Press & Blog

Nerbio's iTOF® Becomes the First FDA-Cleared App-Controlled Neuromuscular Blockade Monitor

San Jose, CA — 05/12/2025 — Nerbio Medical Software Platforms, Inc., a leader in intelligent patient monitoring solutions, proudly announces that its iTOF® device has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This milestone marks iTOF as the world's first wireless, app-controlled quantitative neuromuscular blockade (NMB) monitoring device to achieve FDA clearance.